Compugen Presents Prediction Based Discovery Strategy at "Targets and …MarketWatch (press release)… within the infrastructure and has resulted to date in multiple discoveries, such as the previously disclosed CGEN-928 with potential use for la…
USA TODAYNICE recommends earlier use of Roche's RoActemra for rheumatoid arthritisPMLiVE… for people with RA as a third-line treatment option if DMARDs had been ineffective, and if patients had also both demonstrated an inadequate response to one…
Pixantrone Progresses Toward Approval in the European UnionMedscapeIn addition, the CHMP noted that the benefit of pixantrone appeared to be lower in patients who had used rituximab in the past, and that its benefit was not established when used as a f…
Progressive Sclerodermoid Skin Changes—DiagnosisArchives of DermatologyOur patient was referred to a major regional cancer center and underwent systemic chemotherapy with 5 cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) p…
Dr. Myhill's notes on fatigue, the immune system's energy demands, and RituximabProHealthRituximab is primarily used in cancer chemotherapy. By pure chance a patient who had severe ME received this drug as part of a treatment for her lymphoma a…
Town and Country Doctor Pleads Guilty To Receiving Misbranded Cancer DrugsPatch.comGenerally, “Mabthera” does contain Rituximab, the same active ingredient found in the FDA-approved drug legally used and marketed in the United States called Rituxan…
Pharmacyclics/Janssen Biotech's PCI-32765 Has Earned Decision Resources …EON: Enhanced Online News (press release)Rituximab (Roche/Genentech/Chugai Seiyaku/Zenyaku Kogyo's Rituxan/MabThera) will continue to dominate a more fragmented diffuse …
EMA Grants Conditional Approval Of Pixuvri For B-Cell LymphomaWall Street Journal-Conditional approval will be renewed on a yearly basis until the obligation to provide additional data on rituximab-pretreated patients has been fulfilled. -Applicant, CT…
CORRECTING and REPLACING Pharmacyclics/Janssen Biotech's PCI-32765 Has Earned …Business Wire (press release)Rituximab (Roche/Genentech/Chugai Seiyaku/Zenyaku Kogyo's Rituxan/MabThera) will continue to dominate a more fragmented diffuse large …
FDA and Roche Warn of Counterfeit AvastinPharmaceutical Technology Magazine (blog)Nor have other products including Faslodex (fulvestrant), Neupogen (filgrastim), Rituxan (rituximab) and Herceptin (trastuzumab) available from unapproved suppliers been …